Document is current
Any future updates will be listed below
-
Authors
Maredia, Nawal
Laurie, Cassandra
Ramsay, Tim
MacDonald, Shannon E.
McMillan, Jacqueline
Basta, Nicole E.
Fadel, Shaza A.
Andrew, Melissa K.
Wilson, Kumanan
Chyderiotis, Sandra
Elliott, Stephanie
Bouzanis, Katrina
Barratt, Jane
Sulis, Giorgia
-
Funding
Funding for this research was provided by:
Canadian Immunization Research Network (FRN#178755)
- License Information
-
More Information
Article History
Received: 28 October 2025
Accepted: 30 December 2025
First Online: 8 January 2026
Declarations
:
: This study received ethical approval from the University of Ottawa Health Sciences and Science Research Ethics Board (Approval #H-09-23-9475) and was conducted in accordance with the Declaration of Helsinki and Tri-Council Policy Statement (2022). Potential participants were provided with detailed information about the study, including procedures, risks, confidentiality, and privacy, via an electronic consent form accessible on the study website. Informed consent was obtained from all participants before enrollment. Each participant was assigned a unique identifier to ensure confidentiality.
: Not applicable.
: GS serves as Editorial Board Member for BMC Public Health. KW is a co-founder of CANImmunize Inc. and has served as a member of the safety committees for Medicago and Moderna. MKA reports research grant funding from Icosavax, unrelated to the present manuscript. All other authors have declared that no competing interests exist.
